Skip to content

Ketamine for Postoperative Pain in Bariatric Surgery

The Effects of Ketamine on Postoperative Pain After Intraoperative Remifentanil Infusions in Bariatric Surgery

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03389022
Acronym
KEPOBA
Enrollment
64
Registered
2018-01-03
Start date
2015-07-22
Completion date
2023-06-06
Last updated
2021-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery Candidate, Pain, Postoperative

Brief summary

The aim of this study was to evaluate an effect of pre - incisional single injection of low-dose ketamine on postoperative pain after remifentanil infusion in patients undergoing laparoscopic gastric bypass and gastric plication surgery. Ketamine is an old general anaesthetic. Low doses of it might be used as a adjunct in postoperative analgesia.The investigators expect that the low-dose ketamine reduces postoperative pain after bariatric surgeries.

Detailed description

Effective postoperative pain management enhances early postoperative rehabilitation and may improve outcomes of surgical treatment. New analgetic medications and combinations of these are sought for optimal analgesia with lowest possible incidence of side effects. One of the method of multimodal analgesia is a combination of opioids and adjuvant agents, such as ketamine. To our knowledge, the role of ketamine in the treatment of postoperative pain after bariatric surgeries is poorly researched. The investigators hypothesize that ketamine, acting through the N-methyl-D-aspartate receptor (NMDA) and opioid receptors, provides favourable conditions for adequate post-operative pain management.

Interventions

DRUGKetamine

0,15 mg/kg pre-incisional single bolus dose of ketamine in the operating room.

DRUGSaline

Intravenous injection given pre-incisional in the operating room.

Sponsors

Lithuanian University of Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* II or III The American Society of Anesthesiologists (ASA) physical status * age \> 18 years * bariatric surgery with general remifentanil anesthesia

Exclusion criteria

* anamnesis of using opioids for the treatment of chronic pain * opioid dependence * younger than 18 years

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain intensityOn the first postoperative dayComparison of pain intensity will be recorded in both groups every 15 min in Post Anesthesia Care Unit (PACU) for 2.5 hours. Postoperative pain was treated with boluses of i.v. morphine (3 mg) at 3 min. intervals on request, if pain intensity exceeded the score of 5 according to the Numeric Pain Rating Scale (NPRS) (0-10). After the transfer of patient's to a regular unit, pain intensity was recorded every 6 hours.
Postoperative morphine requirementsOn the first postoperative dayPostoperative morphine requirements will be recorded in both groups in the PACU for 2.5 hours.

Secondary

MeasureTime frameDescription
Incidence of side effectsOn the first postoperative dayIncidence of side effects will be recorded in both groups on the first postoperative day.
Patients' satisfaction with postoperative analgesiaOn the second postoperative dayPatients' satisfaction with postoperative analgesia will be recorded in both groups on the second postoperative day.The subject could express their level of satisfaction in five possible levels, from very satisfied to very dissatisfied.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026